(lp0
S'Journal of Diabetes Science and Technology Publishes Scientific Paper Authored ... PR Newswire  - Apr 4, 2017 JERUSALEM, April 4, 2017 /PRNewswire/ -- Oramed Pharmaceuticals Inc.  , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today a new paper&nbsp;...'
p1
aS'6.34 MarketWatch - Apr 21, 2011 Oramed Pharmaceuticals Inc. Oramed Pharmaceuticals, Inc. engages in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible&nbsp;...'
p2
aS'Oramed Pharmaceuticals Inc. ORMP  Wall Street Journal - Feb 11, 2013 Oramed Pharmaceuticals Inc. ORMP . search. View All companies. AT CLOSE 3:59 PM EDT 04/13/17. $6.26 USD; -0.03 -0.48%.'
p3
aS'Does Oramed Pharmaceuticals Pass The Smell Test? Seeking Alpha - May 23, 2014 First off, thank you to the M.D. and Pharma classmates who helped to explain the intricacies of the clinical trial and drug patent process.'
p4
aS'Oramed: The Atypical Biotechnology Company With Great Upside Potential Seeking Alpha - Jul 1, 2016 Oramed , the biotech company involved in the research and development of orally deliverable insulin, is a great investment opportunity for investors that are looking for a growing small stock in the biotechnology industry.'
p5
aS"Here's Where Oramed Fits Into The Diabetes Space Seeking Alpha - Feb 17, 2017 One company that is attempting to do exactly that right now, and that looks to have an attractive pitch, is Oramed Pharmaceuticals Inc. . The company's CEO, Nadav Kidron, featured on CNBC's Squawk Box earlier this week and highlighted&nbsp;..."
p6
aS"Oramed Pharmaceuticals'  CEO Nadav Kidron Hosts Phase IIb Clinical ... Seeking Alpha - Jul 29, 2016 I encourage you to review the cautionary language about forward-looking statements in today's press release, which can be found on Oramed's website, as well as the Company's filings with the Securities and Exchange Commission including, without&nbsp;..."
p7
aS"Investor Arena: Keeping an Eye on Oramed Pharmaceuticals Inc  Sherwood Daily - 8 hours ago The Williams %R shows how the current closing price compares to previous highs/lows over a specified period. Oramed Pharmaceuticals Inc 's Williams Percent Range or 14 day Williams %R is sitting at -47.06. Typically, if the value heads above -20,&nbsp;..."
p8
aS'Sinopharm Capital-Hefei Signs Letter of Intent with Oramed for $50000000 ... PR Newswire  - Jul 7, 2015 Oramed Pharmaceuticals Inc.  , a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, announced today that it has signed a non-binding Letter of Intent  for an&nbsp;...'
p9
aS"Oramed's Pending Oral Insulin Would Trounce Efforts Of Global Diabetes Titans Seeking Alpha - May 4, 2016 Oramed Pharmaceuticals Inc. , far ahead of its bigger brethren, just got closer to fulfilling this dream. Early last month, Oramed finished its 180-patient Phase IIb clinical trial with ORMD-0801, an oral insulin pill intended to mimic ..."
p10
a.